Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ibuprofen + opioid medication refers to fixed-dose oral combinations of the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen with an opioid analgesic such as oxycodone or hydrocodone. These combinations are used for short-term management of moderate to severe acute pain when other pain medicines are insufficient or not tolerated. Ibuprofen acts by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis involved in inflammation and pain signaling. The opioid component (e.g., oxycodone or hydrocodone) acts primarily as a mu-opioid receptor agonist in the central nervous system to alter perception of and response to pain. These products provide additive analgesic effects from both components but carry risks associated with each class—such as gastrointestinal toxicity and cardiovascular risk from NSAIDs, plus dependence potential and respiratory depression from opioids. They are typically prescribed for short durations (usually less than 7–10 days) due to these risks[1][2][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ibuprofen + opioid medication.